The potential of deferasirox as a novel therapeutic modality in gastric cancerJung Hye Choi(Hanyang University Guri Hospital), Young Yiul Lee(Cancer Research Institute)World Journal of Surgical OncologyMarch 10, 201610.1186/s12957-016-0829-1Cited by 30SaveCiteExport RISWatch citationsRelated PapersChloroquine enhances the chemotherapeutic activity of 5‐fluorouracil in a colon cancer cell line via cell cycle alteration|Apmis|2012|54